The association between total, animal, and plant protein intake and metabolic dysfunction-associated fatty liver disease in overweight and obese children and adolescents

被引：0
作者：
Ali Nikparast [1 ]
Mohammad Hassan Sohouli [2 ]
Kimia Forouzan [1 ]
Mahdi Amani Farani [1 ]
Pooneh Dehghan [3 ]
Pejman Rohani [2 ]
Golaleh Asghari [1 ]
机构：
[1] National Nutrition and Food Technology Research Institute,Department of Clinical Nutrition and Dietetics, Faculty of Nutrition and Food Technology
[2] Shahid Beheshti University of Medical Sciences,Pediatric Gastroenterology and Hepatology Research Center, Pediatrics Centre of Excellence, Children’s Medical Center
[3] Tehran University of Medical Sciences,Department of Imaging
[4] Taleghani Hospital,undefined
[5] Shahid Beheshti University of Medical Sciences,undefined
来源：
Nutrition Journal | / 24卷 / 1期
关键词：
Dietary protein; Children; Adolescent; Obesity; MAFLD; Metabolic dysfunction associated fatty liver disease;
D O I：
10.1186/s12937-025-01142-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes
    Mantovani, Alessandro
    Csermely, Alessandro
    Taverna, Antonio
    Cappelli, Davide
    Benfari, Giovanni
    Bonapace, Stefano
    Byrne, Christopher D.
    Targher, Giovanni
    DIABETES & METABOLISM, 2023, 49 (02)
  • [32] The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease
    Elangovan, Harendran
    Gunton, Jenny Elizabeth
    Zheng, Ming Hua
    Fan, Jian-Gao
    Goh, George Boon Bee
    Gronbaek, Henning
    George, Jacob
    HEPATOLOGY INTERNATIONAL, 2025, : 337 - 348
  • [33] Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
    Li, Hejun
    Luo, Hengcong
    Zhang, Ying
    Liu, Lisi
    Lin, Rong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [34] The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
    Wei, Suosu
    Hao, Yanrong
    Dong, Xiaofeng
    Huang, Junzhang
    Huang, Kai
    Xie, Yujie
    Liu, Hongjun
    Wei, Chunyu
    Xu, Jinan
    Huang, Wei
    Dong, Lingguang
    Yang, Jianrong
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [35] Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents
    Cardoso, Anajas S.
    Gonzaga, Nathalia C.
    Medeiros, Carla C. M.
    de Carvalho, Danielle F.
    JORNAL DE PEDIATRIA, 2013, 89 (04) : 412 - 418
  • [36] Impact of the new definition of metabolic dysfunction-associated fatty liver disease on detection of significant liver fibrosis in US adolescents
    Ciardullo, Stefano
    Carbone, Marco
    Invernizzi, Pietro
    Perseghin, Gianluca
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (08) : 2070 - 2078
  • [37] Association of the Metabolic Dysfunction-Associated Fatty Liver Disease with Serum Uric Acid-to-Creatinine Ratio
    Han, A. Lum
    Lee, Hee Kyung
    METABOLIC SYNDROME AND RELATED DISORDERS, 2022, 20 (07) : 370 - 376
  • [38] Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
    Beygi, Mohammad
    Ahi, Salma
    Zolghadri, Samaneh
    Stanek, Agata
    NUTRIENTS, 2024, 16 (14)
  • [39] Risk scores for metabolic dysfunction-associated fatty liver disease in pediatric obesity
    Lischka, Julia
    Lieb, Katharina
    Schanzer, Andrea
    Hojreh, Azadeh
    Ba-Ssalamah, Ahmed
    de Gier, Charlotte
    Walleczek, Nina-Katharina
    Zeyda, Maximilian
    Greber-Platzer, Susanne
    ANNALS OF NUTRITION AND METABOLISM, 2022, 78 (05) : 247 - 254
  • [40] Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implications
    Hu, Shuwei
    Ai, Yingjie
    Hu, Chencheng
    Bawa, Fathima N. Cassim
    Xu, Yanyong
    GENES & DISEASES, 2025, 12 (03)
12345